Prior to first in human use, all new drugs must pass rigorous safety tests in well controlled preclinical or non-clinical studies. Regulated under Good Laboratory Practices (GLPs) to ensure stringent integrity of the data, such studies can often make or break further development of a new chemical entity. CfPA courses can prepare you to effectively design, develop, structure, source, execute, and analyze studies during this critical discovery phase, giving your novel molecule the best chance of success.

No new drug is ever approved and launched into the market without having first been shown to be safe and effective in human subjects. These human trials are controlled clinical studies administered in accordance with regulatory practices and strict, previously approved protocols. Training in how to effectively develop and execute such studies during Phase 1, Phase 2, and Phase 3 drug development can make the difference between highly successful studies and costly failures.

CFPA CERTIFICATION PROGRAMS
Our exclusive certification programs are the perfect way to validate your skills and advance your career. Completely ONLINE, no application process, and no extra costs. Click here to learn more about the different certification programs we can offer you, or chat with us now!

Looking for a training solution to specifically address challenges your organization is facing? With Custom Team Training we will deliver any course at your location - targeting your company’s specific learning needs or goals. Choose from our core courses, or we can fully customize a course. Contact us to learn more.

Clinical/Non-Clinical